About

Company description

We are Ardena, a reputable contract partner delivering drug development, manufacturing, logistics and (bio)analytical services to pharmaceutical customers globally.  In parallel, we work with you to compile your regulatory dossier and to fast track your product towards compliance.  Every day, we guide companies through the hurdles and challenges of drug development.  Our integrated service offering helps to streamline the drug's progress to clinic and beyond. Ardena is your one source contractor for the chemical and pharmaceutical development of your valued compounds.  In parallel, we provide you with full product analytical and bioanalytical support during development.  Our dossier centric approach makes a difference.  We work with you to compile your regulatory dossier in parallel with drug development, saving you time, identifying hurdles and fast tracking your product to compliance.  We are experts in writing and formatting supporting CMC documentation.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; North America
Affiliated categories: API Contract Manufacturing |Formulation development |Finished Dosage Forms More

Upcoming events

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany Visit us at stand 121H33 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain We were at stand 3A1 See our Exhibitor Profile   See full Exhibitor List
18 apr 2018

CPhI Japan 2018

18 - 20 April 2018 Tokyo, Japan See our Exhibitor Profile   See full Exhibitor List
24 oct 2017

CPhI Worldwide 2017

24 - 26 October 2017 Messe Frankfurt, Germany We were at stand 40B12 See our Exhibitor Profile   See full Exhibitor List

News about Ardena

Ardena launches bimonthly newsletter in 2019

17 May 2019

Ardena launches bimonthly newsletter in 2019

We are excited to launch our bimonthly newsletter, which is specifically designed to help biotech and pharma companies succeed in their drug development endeavors. The primary objective of our newsletter is to provide guidance on how to address commonly encountered drug.

Read more

12 Nov 2018

Ardena cements growth and expansion with new HQ

Larger headquarters will enable the company to free up space for additional laboratories and further expand capabilities.

Read more

8 May 2018

Ardena acquisition strengthens API offering

Acquisition enables Ardena to manufacture batch sizes up to 100 kg.

Read more

25 Oct 2017

Ardena launches following Pharmavize and Crystallics merger

A new contract development and manufacturing organisation (CDMO), Ardena, has launched following the merging of Pharmavize and Crystallics.

Read more
Ardena

Contact information

Address

Telephone

Website

View all contact information